Valneva SE (VALN) Inventory Average (2022 - 2026)
Valneva SE's (VALN) quarterly Inventory Average came in at $58.8 million in Q1 2026, down 3.71% year-on-year from $61.1 million in Q1 2025, and down 11.93% quarter-over-quarter from $66.8 million in Q4 2025.
Valneva SE (VALN) Inventory Average (2022 - 2026) Analysis & Trends
Valneva SE has disclosed Inventory Average across 5 years of filings, most recently posting $58.8 million for Q1 2026.
- Inventory Average for Q1 2026 came in at $58.8 million, down 3.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.8 million (down 3.71% YoY), and the FY2025 annual result was $57.9 million, up 10.11% from the prior year.
- Inventory Average came in at $58.8 million for Q1 2026 at Valneva SE, down from $66.8 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $149.4 million in Q1 2022 to a low of $38.8 million in Q1 2023.
- The 5-year median for Inventory Average is $60.4 million (2024), against an average of $67.9 million.
- Across the five-year window, Inventory Average tumbled 74.0% in 2023 and jumped 49.49% in 2024, its largest moves.
- Valneva SE's Inventory Average stood at $66.5 million in 2022, then plunged by 32.96% to $44.6 million in 2023, then soared by 35.47% to $60.4 million in 2024, then increased by 10.57% to $66.8 million in 2025, then slipped by 11.93% to $58.8 million in 2026.
- The last three Inventory Average figures came in at $58.8 million (Q1 2026), $66.8 million (Q4 2025), and $72.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | 58.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.85 Mn |
| Dec 31, 2025 | 66.82 Mn |
| Sep 30, 2025 | 72.52 Mn |
| Jun 30, 2025 | 67.38 Mn |
| Mar 31, 2025 | 61.11 Mn |
| Dec 31, 2024 | 60.43 Mn |
| Sep 30, 2024 | 58.07 Mn |
| Jun 30, 2024 | 52.70 Mn |
| Mar 31, 2024 | 50.31 Mn |
| Dec 31, 2023 | 44.60 Mn |
| Sep 30, 2023 | 38.84 Mn |
| Jun 30, 2023 | 39.09 Mn |
| Mar 31, 2023 | 38.84 Mn |
| Dec 31, 2022 | 66.54 Mn |
| Sep 30, 2022 | 99.42 Mn |
| Jun 30, 2022 | 129.20 Mn |
| Mar 31, 2022 | 149.39 Mn |